An International Conference dedicated to the treatment of diabetes was held in Osaka, Japan. The leading specialist of the Swiss Medica clinic group, Dr. Nikolai Vorobyov, commented on the presentations.
International Conference on Diabetes and its Complications was held on 28-29 May 2018 in Osaka, Japan.
This annual conference provides an opportunity for professionals in the field of diabetes to share knowledge and experience, as well as to establish useful business relationships.
Every year famous scientists, doctors, young researchers, heads of manufacturing enterprises, and students from the field of diabetic medicine gather at the conference. In close collaboration, specialists come up with new ideas, and a powerful impetus for the development of the field appears.
OMICS Conference Series Ltd Publishing Group provided professionals with the opportunity to publish their works in more than 700 popular journals and has already hosted more than 1,000 scientific conferences around the world. The current meeting on diabetes treatment is just one of them.
Diabetic Complications-2018 Conference brought together a lot of scientists and practitioners. Experience and theoretical knowledge combined to explore new opportunities in the treatment of diabetes.
Dr. N.V. Vorobyov, “IMR-therapy is a new way of diabetes treatment”
Scientists and experts in the field of diabetes from all over the world closely followed the conference. A Russian specialist, Dr. Nikolai Vorobyov, became one of them. In his practice, he uses a well-known technique, IMR-therapy (Intracellular Metabolism Remediation), which proved to be effective in the treatment of type 2 diabetes. This technique allows doctors to prepare the body for cell therapy and increase the sensitivity/activity of cells.
IMR-therapy is also used in the treatment of cardiovascular diseases, multiple sclerosis, and joint conditions.
Diabetes Therapy Market
Diabetes increasingly becomes a disease associated with the lifestyle. Now both young and elderly people suffer from it.
In 2016, the diabetes therapy market in Asia-Pacific (APAC) countries, by some estimates, amounted to $7.5 billion. According to forecasts, with an average annual growth of 7.1%, over the 2013 to 2020 period, the market will grow to $10.5 billion.
Among the four major economies of China, India, Japan, and Australia, it is China that will experience the fastest growth (11.1% during the forecast period).
This will be due to both population growth and urbanization/improved quality of life. The market growth will also be significantly affected by the release of new drugs.
Published by Erika Rhea